Los Angeles Capital Management & Equity Research Inc. increased its stake in WebMD Health Corp (NASDAQ:WBMD) by 33.4% during the third quarter, Holdings Channel reports. The firm owned 16,956 shares of the company’s stock after buying an additional 4,248 shares during the period. Los Angeles Capital Management & Equity Research Inc.’s holdings in WebMD Health Corp were worth $843,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. LS Investment Advisors LLC bought a new position in shares of WebMD Health Corp during the second quarter valued at about $134,000. Old Mutual Global Investors UK Ltd. bought a new stake in WebMD Health Corp during the second quarter worth $5,335,000. Winslow Evans & Crocker Inc. increased its stake in WebMD Health Corp by 71.4% in the second quarter. Winslow Evans & Crocker Inc. now owns 15,000 shares of the company’s stock worth $872,000 after buying an additional 6,250 shares during the last quarter. New York State Teachers Retirement System bought a new stake in WebMD Health Corp during the second quarter worth $872,000. Finally, Bank of Montreal Can bought a new stake in WebMD Health Corp during the second quarter worth $9,028,000. Institutional investors own 86.08% of the company’s stock.

Institutional Ownership by Quarter for WebMD Health Corp (NASDAQ:WBMD)

WebMD Health Corp (NASDAQ:WBMD) traded up 0.41% during trading on Friday, hitting $50.99. 686,818 shares of the stock were exchanged. WebMD Health Corp has a 52 week low of $45.46 and a 52 week high of $67.55. The stock has a market cap of $1.92 billion, a P/E ratio of 28.49 and a beta of 0.36. The stock has a 50 day moving average of $52.05 and a 200-day moving average of $53.67.

WebMD Health Corp (NASDAQ:WBMD) last posted its earnings results on Tuesday, November 1st. The company reported $0.47 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.07. The business had revenue of $171.40 million for the quarter, compared to the consensus estimate of $169.96 million. WebMD Health Corp had a net margin of 11.97% and a return on equity of 35.64%. The company’s revenue for the quarter was up 12.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.32 EPS. Equities analysts expect that WebMD Health Corp will post $1.90 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This story was originally posted by Daily Political and is the propert of of Daily Political. If you are accessing this story on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The original version of this story can be accessed at http://www.dailypolitical.com/2017/01/13/webmd-health-corp-wbmd-shares-bought-by-los-angeles-capital-management-equity-research-inc.html.

A number of research firms recently weighed in on WBMD. Zacks Investment Research upgraded WebMD Health Corp from a “hold” rating to a “buy” rating and set a $57.00 price objective for the company in a report on Thursday, October 20th. Mizuho restated a “buy” rating and issued a $63.00 price objective (down from $68.00) on shares of WebMD Health Corp in a report on Monday, September 19th. Raymond James Financial, Inc. downgraded WebMD Health Corp from a “strong-buy” rating to an “outperform” rating and set a $60.00 price objective for the company. in a report on Monday, December 12th. Pacific Crest restated a “buy” rating and issued a $72.00 price objective on shares of WebMD Health Corp in a report on Sunday, December 4th. Finally, Leerink Swann restated a “buy” rating on shares of WebMD Health Corp in a report on Wednesday, September 28th. Five investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. WebMD Health Corp presently has a consensus rating of “Buy” and an average price target of $65.96.

In other news, Chairman Martin J. Wygod sold 14,321 shares of the firm’s stock in a transaction dated Thursday, December 22nd. The shares were sold at an average price of $55.00, for a total value of $787,655.00. Following the sale, the chairman now directly owns 134,637 shares in the company, valued at approximately $7,405,035. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Chairman Martin J. Wygod sold 89,843 shares of the firm’s stock in a transaction dated Monday, November 21st. The shares were sold at an average price of $53.94, for a total transaction of $4,846,131.42. Following the completion of the sale, the chairman now owns 156,591 shares in the company, valued at $8,446,518.54. The disclosure for this sale can be found here. Company insiders own 8.10% of the company’s stock.

About WebMD Health Corp

WebMD Health Corp. is a provider of health information services. The Company provides its services to consumers, physicians and other healthcare professionals, employers and health plans through its public and private online portals, mobile platforms and health-focused publications. The WebMD Health Network includes: www.WebMD.com, its primary public portal for consumers and related mobile-optimized sites and mobile apps; www.Medscape.com, its primary public portal for physicians and other healthcare professionals and related mobile services; and other sites through which, the Company provides its branded health and wellness content, tools and services.

5 Day Chart for NASDAQ:WBMD

Want to see what other hedge funds are holding WBMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for WebMD Health Corp (NASDAQ:WBMD).

Receive News & Ratings for WebMD Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WebMD Health Corp and related companies with MarketBeat.com's FREE daily email newsletter.